Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling
申请人:CELL THERAPEUTICS, INC.
公开号:EP1690864A2
公开(公告)日:2006-08-16
Novel tricyclic compounds are found to be useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling.
新型三环化合物可用于治疗或预防与受细胞因子细胞内信号传导影响的疾病或紊乱有关的症状或表现。